These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28885613)

  • 1. MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia.
    Zhang T; Davidson-Moncada JK; Mukherjee P; Furman RR; Bhavsar E; Chen Z; Hakimpour P; Papavasiliou N; Tam W
    Blood Cancer J; 2017 Sep; 7(9):e606. PubMed ID: 28885613
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia.
    Srivastava S; Tsongalis GJ; Kaur P
    Clin Biochem; 2013 Jul; 46(10-11):901-8. PubMed ID: 23518313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of miRNAs in diagnosis and prognosis.
    Tsongalis GJ; Lockwood CM
    Clin Biochem; 2013 Jul; 46(10-11):839. PubMed ID: 23726293
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA expression in chronic lymphocytic leukaemia.
    Lawrie CH; Ballabio E; Dyar OJ; Jones M; Ventura R; Chi J; Tramonti D; Gooding S; Boultwood J; Wainscoat JS; Hatton CS; Schuh A
    Br J Haematol; 2009 Nov; 147(3):398-402. PubMed ID: 19681887
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 6. From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia.
    Thurgood LA; Chataway TK; Lower KM; Kuss BJ
    J Proteomics; 2017 Feb; 155():73-84. PubMed ID: 28069558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement.
    Maffei R; Fiorcari S; Martinelli S; Guarnotta C; Benatti S; Belmonte B; Potenza L; Luppi M; Marasca R
    Hematol Oncol; 2018 Feb; 36(1):372-375. PubMed ID: 28580615
    [No Abstract]   [Full Text] [Related]  

  • 8. Thioredoxin-interacting protein and chronic lymphocytic leukemia.
    Friday E; Koshy N; Bhanderi V; Turturro F
    Leuk Lymphoma; 2012 Mar; 53(3):492-4. PubMed ID: 21916829
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a novel tRNA-derived RNA fragment exhibiting high prognostic potential in chronic lymphocytic leukemia.
    Karousi P; Katsaraki K; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Hematol Oncol; 2019 Oct; 37(4):498-504. PubMed ID: 30945323
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNAs and leukemias: how strong is the connection?
    Calin GA; Garzon R; Cimmino A; Fabbri M; Croce CM
    Leuk Res; 2006 Jun; 30(6):653-5. PubMed ID: 16330098
    [No Abstract]   [Full Text] [Related]  

  • 11. Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia.
    Yun S; Zhang L; Patel MR; Knepper TC; Chavez JC; Pinilla-Ibarz J
    Blood; 2018 Mar; 131(11):1258-1261. PubMed ID: 29437555
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of microRNAs in chronic lymphocytic leukemia (Review).
    Zhou XX; Wang X
    Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia.
    Vargova K; Pesta M; Obrtlikova P; Dusilkova N; Minarik L; Vargova J; Berkova A; Zemanova Z; Michalova K; Spacek M; Trneny M; Stopka T
    Blood Cancer J; 2017 Jul; 7(7):e585. PubMed ID: 28731457
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
    Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
    Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
    Nicoloso MS; Kipps TJ; Croce CM; Calin GA
    Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA let-7b regulates genomic balance by targeting Aurora B kinase.
    Mäki-Jouppila JH; Pruikkonen S; Tambe MB; Aure MR; Halonen T; Salmela AL; Laine L; Børresen-Dale AL; Kallio MJ
    Mol Oncol; 2015 Jun; 9(6):1056-70. PubMed ID: 25682900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling.
    Filarsky K; Garding A; Becker N; Wolf C; Zucknick M; Claus R; Weichenhan D; Plass C; Döhner H; Stilgenbauer S; Lichter P; Mertens D
    Haematologica; 2016 Jun; 101(6):e249-53. PubMed ID: 27081174
    [No Abstract]   [Full Text] [Related]  

  • 18. Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.
    Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Vago P; Travade P; Tchirkov A
    Leukemia; 2008 Jun; 22(6):1291-3. PubMed ID: 18046444
    [No Abstract]   [Full Text] [Related]  

  • 19. Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia.
    Acunzo M; Croce CM
    Clin Chem; 2016 Apr; 62(4):655-6. PubMed ID: 26908869
    [No Abstract]   [Full Text] [Related]  

  • 20. [Expression of microRNA-223 in lymphocytic leukemia cells and its action mechanism].
    Nan Z; Liang Y; Fu R; Liu H; Ruan EB; Wang XM; Wang GJ; Qu W; Liu H; Wu YH; Song J; Xing LM; Guan J; Li LJ; Wang HQ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):556-61. PubMed ID: 23815897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.